These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 36861362)
1. Interplay Between Extracellular Matrix Remodeling and Angiogenesis in Tumor Ecosystem. Siddhartha R; Garg M Mol Cancer Ther; 2023 Mar; 22(3):291-305. PubMed ID: 36861362 [TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinase-19 inhibits growth of endothelial cells by generating angiostatin-like fragments from plasminogen. Brauer R; Beck IM; Roderfeld M; Roeb E; Sedlacek R BMC Biochem; 2011 Jul; 12():38. PubMed ID: 21787393 [TBL] [Abstract][Full Text] [Related]
3. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives. Mao X; Xu J; Wang W; Liang C; Hua J; Liu J; Zhang B; Meng Q; Yu X; Shi S Mol Cancer; 2021 Oct; 20(1):131. PubMed ID: 34635121 [TBL] [Abstract][Full Text] [Related]
4. Tumor Microenvironment and Nitric Oxide: Concepts and Mechanisms. Vedenko A; Panara K; Goldstein G; Ramasamy R; Arora H Adv Exp Med Biol; 2020; 1277():143-158. PubMed ID: 33119871 [TBL] [Abstract][Full Text] [Related]
5. The role of matrix stiffness in cancer stromal cell fate and targeting therapeutic strategies. Wei J; Yao J; Yan M; Xie Y; Liu P; Mao Y; Li X Acta Biomater; 2022 Sep; 150():34-47. PubMed ID: 35948177 [TBL] [Abstract][Full Text] [Related]
6. Targeting the microenvironment in solid tumors. Belli C; Trapani D; Viale G; D'Amico P; Duso BA; Della Vigna P; Orsi F; Curigliano G Cancer Treat Rev; 2018 Apr; 65():22-32. PubMed ID: 29502037 [TBL] [Abstract][Full Text] [Related]
7. Breast cancer cells alter the dynamics of stromal fibronectin-collagen interactions. Wang K; Wu F; Seo BR; Fischbach C; Chen W; Hsu L; Gourdon D Matrix Biol; 2017 Jul; 60-61():86-95. PubMed ID: 27503584 [TBL] [Abstract][Full Text] [Related]
8. Stromal miR-200s contribute to breast cancer cell invasion through CAF activation and ECM remodeling. Tang X; Hou Y; Yang G; Wang X; Tang S; Du YE; Yang L; Yu T; Zhang H; Zhou M; Wen S; Xu L; Liu M Cell Death Differ; 2016 Jan; 23(1):132-45. PubMed ID: 26068592 [TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinases and angiogenesis. Rundhaug JE J Cell Mol Med; 2005; 9(2):267-85. PubMed ID: 15963249 [TBL] [Abstract][Full Text] [Related]
10. Extracellular matrix (ECM) stiffness and degradation as cancer drivers. Najafi M; Farhood B; Mortezaee K J Cell Biochem; 2019 Mar; 120(3):2782-2790. PubMed ID: 30321449 [TBL] [Abstract][Full Text] [Related]
11. The Tumor Microenvironment in Tumorigenesis and Therapy Resistance Revisited. Dzobo K; Senthebane DA; Dandara C Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672326 [TBL] [Abstract][Full Text] [Related]
12. Cancer-associated fibroblasts in desmoplastic tumors: emerging role of integrins. Zeltz C; Primac I; Erusappan P; Alam J; Noel A; Gullberg D Semin Cancer Biol; 2020 May; 62():166-181. PubMed ID: 31415910 [TBL] [Abstract][Full Text] [Related]
13. Angiogenesis. Senger DR; Davis GE Cold Spring Harb Perspect Biol; 2011 Aug; 3(8):a005090. PubMed ID: 21807843 [TBL] [Abstract][Full Text] [Related]
14. The landscape of cancer-associated fibroblasts in colorectal cancer liver metastases. Giguelay A; Turtoi E; Khelaf L; Tosato G; Dadi I; Chastel T; Poul MA; Pratlong M; Nicolescu S; Severac D; Adenis A; Sgarbura O; Carrère S; Rouanet P; Quenet F; Ychou M; Pourquier D; Colombo PE; Turtoi A; Colinge J Theranostics; 2022; 12(17):7624-7639. PubMed ID: 36438498 [No Abstract] [Full Text] [Related]
15. Targeting extracellular matrix stiffness and mechanotransducers to improve cancer therapy. Jiang Y; Zhang H; Wang J; Liu Y; Luo T; Hua H J Hematol Oncol; 2022 Mar; 15(1):34. PubMed ID: 35331296 [TBL] [Abstract][Full Text] [Related]
16. Decoding the mechanism of vascular morphogenesis to explore future prospects in targeted tumor therapy. Venkatakrishnan G; Parvathi VD Med Oncol; 2022 Aug; 39(11):178. PubMed ID: 36036322 [TBL] [Abstract][Full Text] [Related]
17. Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments. Yuan Z; Li Y; Zhang S; Wang X; Dou H; Yu X; Zhang Z; Yang S; Xiao M Mol Cancer; 2023 Mar; 22(1):48. PubMed ID: 36906534 [TBL] [Abstract][Full Text] [Related]
18. Cancer associated fibroblasts: is the force the path to the dark side? Barbazán J; Matic Vignjevic D Curr Opin Cell Biol; 2019 Feb; 56():71-79. PubMed ID: 30308331 [TBL] [Abstract][Full Text] [Related]
19. Extracellular matrix remodeling in the tumor immunity. Du W; Xia X; Hu F; Yu J Front Immunol; 2023; 14():1340634. PubMed ID: 38332915 [TBL] [Abstract][Full Text] [Related]
20. The Interplay between Extracellular Matrix Remodeling and Cancer Therapeutics. Prakash J; Shaked Y Cancer Discov; 2024 Aug; 14(8):1375-1388. PubMed ID: 39091205 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]